The role of myeloid colony-stimulating factors in the treatment of acute lymphoblastic leukemia – more questions than answers?

References

• Ohsaka A, Kitagawa S, Sakamoto S, et al In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989;74:2743–2748.
   PubMed Web of Science ®Google Scholar
• Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791–2808.
   PubMed Web of Science ®Google Scholar
• Hallböök H, Björkholm M, Hägglund H, et al Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? Leuk Lymphoma 2009;50:1872–1874.
   PubMed Web of Science ®Google Scholar
• Geissler K, Koller E, Hubmann E, et al Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia – a randomized phase-III study. Blood 1997;90:590–596.
   PubMed Web of Science ®Google Scholar
• Ottmann OG, Hoelzer D, Gracien E, et al Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood 1995;86:444–450.
   PubMed Web of Science ®Google Scholar
• Thomas X, Boiron JM, Huguet F, et al Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. Hematol J 2004;5:384–394.
   PubMedGoogle Scholar
• Larson RA, Dodge RK, Linker CA, et al A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998;92:1556–1564.
   PubMed Web of Science ®Google Scholar
• Holowiecki J, Giebel S, Krzemien S, et al G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter study. Leuk Lymphoma 2002;43:315–325.
   PubMed Web of Science ®Google Scholar
• Sasse EC, Sasse AD, Brandalise S, et al Colony-stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. Cochrane Database Syst Rev 2005;3: CD004139.
   PubMedGoogle Scholar
• Sung L, Alibhai SM, Beyene J, et al Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials. Leukemia 2009;23:811–813.
   PubMed Web of Science ®Google Scholar
• Becker PS. Growth factor priming in therapy of acute myelogenous leukemia. Curr Hematol Rep 2004;3:413–418.
   PubMedGoogle Scholar
• Inatomi Y, Toyama K, Clark SC, et al Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia. Cancer Res 1994;54:455–462.
   PubMed Web of Science ®Google Scholar
• Lowenberg B, van Putten W, Theobald M, et al Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003;349:743–752.
   PubMed Web of Science ®Google Scholar
• Wheatley K, Goldstone AH, Littlewood T, et al Randomized placebo-controlled trial of granulocyte colony-stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party. Br J Haematol 2009;146:54–63.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Arima N, Ohtsubo H, et al Granulocyte-colony-stimulating factor-induced proliferation of primary adult T-cell leukaemia cells. Br J Haematol 1997;96:715–723.
   PubMed Web of Science ®Google Scholar
• Shinjo K, Takeshita A, Ohnishi K, et al Granulocyte colony-stimulating factor receptor at various differentiation stages of normal and leukemic hematopoietic cells. Leuk Lymphoma 1997;25:37–46.
   PubMed Web of Science ®Google Scholar
• Mielcarek M, Martin PJ, Torok-Storb B. Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997;89:1629–1634.
   PubMed Web of Science ®Google Scholar
• Rutella S, Zavala F, Danese S, et al Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 2005;175:7085–7091.
   PubMed Web of Science ®Google Scholar
• Tanaka J, Mielcarek M, Torok-Storb B. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 1998;91:347–352.
   PubMed Web of Science ®Google Scholar